News | Women's Health | October 14, 2016

New CDC Study Shows Changes in Breast Cancer Death Rates by Age Group

Improved education, access to more personalized and cutting-edge treatment led to overall decline in death rates; death rate for black women, however, still considerably higher than white women

CDC study, breast cancer death rates, age group, race

October 14, 2016 — Breast cancer death rates among women decreased during 2010-2014, but racial differences persisted, according to a study by the Centers for Disease Control and Prevention (CDC) in this week’s Morbidity and Mortality Weekly Report.

The findings show changes for death rates from breast cancer by age group for black and white women, the groups with the highest death rates in the United States.

“Our latest data suggest some improvement for black women when it comes to disparities,” said Lisa Richardson, M.D., director of CDC’s Division of Cancer Prevention and Control. “First, the decline in deaths suggests that white and black women under 50 are benefitting equally from cancer treatments. Second, we’re hopeful the lack of difference in death rates between black and white women under 50 will start to be seen in older women.”

Data highlights include:

  • There was a faster decrease in breast cancer death rates for white women (1.9 percent per year) than black women (1.5 percent per year) between 2010 and 2014;
  • Among women under age 50, breast cancer death rates decreased at the same pace for black and white women; and
  • The largest difference by race was among women ages 60–69 years: Breast cancer death rates dropped 2 percent per year among white women, compared with 1 percent per year among black women.

The authors noted that the drop in death rates among women may be due to improved education about the importance of appropriate breast cancer screening and treatment, as well as women having access to personalized and cutting-edge treatment.

“The good news is that overall rates of breast cancer are decreasing among black women. However, when compared with white women, the likelihood that a black woman will die after a breast cancer diagnosis is still considerably higher,” said Jacqueline Miller, M.D., and medical director of CDC’s National Breast and Cervical Cancer Early Detection Program.

Personalized medical treatments combined with community-based cancer control efforts that ensure adequate follow-up and treatment after a cancer diagnosis could help decrease breast cancer death rates faster and reduce differences among black and white women.

Women can take steps to help reduce their breast cancer risk by knowing their family history of cancer, being physically active, eating a healthy diet, maintaining a healthy weight and getting recommended cancer screenings.

CDC’s National Breast and Cervical Cancer Early Detection Program provides access to timely breast and cervical cancer screening and diagnostic services for low-income, uninsured and underserved women. It is the largest organized cancer screening program in the United States and offers free or low-cost mammograms to women who qualify.

CDC’s Bring Your Brave campaign provides information about breast cancer to women younger than age 45 by sharing real stories about young women whose lives have been affected by breast cancer.

The United States Cancer Statistics web-based report contains the official federal statistics on newly diagnosed cancer cases. CDC and the National Cancer Institute have combined their cancer incidence data sources to produce these statistics. Mortality data are from CDC's National Vital Statistics System. CDC provides support for states and territories to maintain registries that provide high-quality data through the National Program of Cancer Registries.

For more information: www.cdc.gov

Related Content

The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...
Etta Pisano Named American College of Radiology Chief Research Officer
News | Radiology Business | October 25, 2018
October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...